Nasdaq · Healthcare
BRUKER CORP (BRKR)
As-reported financials and recent SEC filings for BRUKER CORP, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$3.44B
Net income
$-8.6M
Net margin
-0.3%
Diluted EPS
$-0.15
ROE
-0.3%
P/E (TTM)
—
Market cap
$9.27B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B |
| Gross profit | $1.58B | $1.65B | $1.51B | $1.31B | $1.21B |
| Operating income | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M |
| Net income | $-8.6M | $113.1M | $427.2M | $296.6M | $277.1M |
| Diluted EPS | $-0.15 | $0.76 | $2.90 | $0.00 | $0.00 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-16
View on EDGAR →1442026-06-15
View on EDGAR →S-3ASR2026-06-12
View on EDGAR →SD2026-05-29
View on EDGAR →8-K/A2026-05-29
View on EDGAR →8-K2026-05-21
View on EDGAR →42026-05-19
View on EDGAR →42026-05-18
View on EDGAR →Go deeper on BRKR
Search BRUKER CORP’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.